| Name | (R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione |
|---|---|
| Synonyms |
T56 BVNVJ C1YQ1MR D- AT6NV DOTJ &&R Form
2-[(2R)-2-Hydroxy-3-[4-(3-oxo-mprpholinyl)phenyl]aminopropyl]-1H-isoindole-1,3-(2H)-dione 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL] 2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione 2-[(2R)-2-hydroxy-3-[4-(3-oxomorpholin-4-yl)anilino]propyl]isoindole-1,3-dione 4-[((2R)-Hydroxy-3-phthaliMido)propylaMine]phenyl-3-Morpholinone Rivoxaban Impurity 50 Rivoxaban Phthalamide [oxazolidone ring opend] impurity Rivoxaban Phthalimido Analog 2-[(2R)-2-hydroxy-3-{[4-(3-oxoMorpholin-4-yl)phenyl]amino}p ropyl]-1H-isoindole-1,3(2H)-dione 2-[(2R)-2-Hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl]-1H-isoindole-1,3(2H)-dione TIANFUCHEM-446-5--1H-ISOINDOLE-1,3(2H)-DIONE, 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL] 2-(2-Hydroxy-3-((4-(3-oxomorpholino) Rivoxaban Intermediates I R –(2-Hydroxy-3-((4-(3-Oxo morpholino) Phenyl) Amino) Propyl) Isoindoline-1,3-dione 2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-Morpho linyl)phenyl]amino]propyl]-1H-isoindole-1 (R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione (Intermediate of Rivoxaban) C21H2IN3Os 2-[(2R)-2-hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}pr 2-Amino-12-picoline Intermediate of Rivoxaban 4 (R)-2-{2-Hydroxy-3-[4-(3-oxo-morpholin-4-yl)-phenylamino]-propyl}-isoindole-1,3-dione 1H-ISOINDOLE-1,3(2H)-DIONE, 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL] Rivoxaban interMediate B Rivoxaban Phthalimido Descbonyl Impurity 2-[(2R)-2-Hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl]-1H-isoindole-1,3(2H)-dione H-ISOINDOLE-1,3(2H)-DIONE, 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL] Rivoxaban Impurity 10/4-[((2R)-Hydroxy-3-phthalimido)propylamine]phenyl-3-morpholinone (R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)-amino)propyl)isoindoline-1,3-dione |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 734.9±60.0 °C at 760 mmHg |
| Molecular Formula | C21H21N3O5 |
| Molecular Weight | 395.409 |
| Flash Point | 398.3±32.9 °C |
| Exact Mass | 395.148132 |
| PSA | 99.18000 |
| LogP | 1.02 |
| Vapour Pressure | 0.0±2.5 mmHg at 25°C |
| Index of Refraction | 1.672 |
|
~93%
446292-07-5 |
| Literature: Roehrig, Susanne; Straub, Alexander; Pohlmann, Jens; Lampe, Thomas; Pernerstorfer, Josef; Schlemmer, Karl-Heinz; Reinemer, Peter; Perzborn, Elisabeth Journal of Medicinal Chemistry, 2005 , vol. 48, # 19 p. 5900 - 5908 |
|
~93%
446292-07-5 |
| Literature: APOTEX PHARMACHEM INC.; BODHURI, Prabhudas; WEERATUNGA, Gamini Patent: WO2012/51692 A1, 2012 ; Location in patent: Page/Page column 42-43 ; |
|
~%
446292-07-5 |
| Literature: BAYER HEALTHCARE AG Patent: US2010/160301 A1, 2010 ; US 20100160301 A1 |
|
~%
446292-07-5 |
| Literature: SYMED LABS LIMITED; MOHAN RAO, dodda; KRISHNA REDDY, pingili; ANNA REDDY, ambati; VENKAT REDDY, buthukuri Patent: WO2012/32533 A2, 2012 ; Location in patent: Page/Page column 16 ; |
|
~%
446292-07-5 |
| Literature: CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PRASAD, Ashok; PAL, Daya, Ram; SHARMA, Mukul, Hari, Prasad; JAIN, Kuldeep, Natwarlal; PATEL, Naitik, Bharatbhai Patent: WO2013/98833 A2, 2013 ; |
|
~%
446292-07-5 |
| Literature: CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PRASAD, Ashok; PAL, Daya, Ram; SHARMA, Mukul, Hari, Prasad; JAIN, Kuldeep, Natwarlal; PATEL, Naitik, Bharatbhai Patent: WO2013/98833 A2, 2013 ; |
|
~%
446292-07-5 |
| Literature: CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PRASAD, Ashok; PAL, Daya, Ram; SHARMA, Mukul, Hari, Prasad; JAIN, Kuldeep, Natwarlal; PATEL, Naitik, Bharatbhai Patent: WO2013/98833 A2, 2013 ; |
|
~%
446292-07-5 |
| Literature: FARMAK, A.S.; URBASEK, Miroslav; HRADIL, Pavel; GREPL, Martin; FIALOVA, Petra; OREMUS, Vladimir; SLEZAR, Petr Patent: WO2012/41263 A2, 2012 ; |
|
~%
446292-07-5 |
| Literature: APOTEX PHARMACHEM INC.; BODHURI, Prabhudas; WEERATUNGA, Gamini Patent: WO2012/51692 A1, 2012 ; |
| Precursor 8 | |
|---|---|
| DownStream 2 | |